Clinical Trial Update: Efficacy and Safety of Nilotinib in Patients With a Chronic Disease of the Graft Against the Host [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial assessing the efficacy and safety of nilotinib in patients with chronic graft-versus-host disease.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Graft-versus-host Disease

Drugs mentioned

• Nilotinib (nilotinib)

Snippet

Sponsor: University Hospital, Lille | Conditions: Graft Versus Host Disease | Phase 2 | Status: COMPLETED